Significance of Neutrophil-to-lymphocyte Ratio in Western Advanced EGFR-mutated Non-small Cell Lung Cancer Receiving a Targeted Therapy
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Significance of Neutrophil-to-lymphocyte Ratio in Western Advanced EGFR-mutated Non-small Cell Lung Cancer Receiving a Targeted Therapy
Authors
Keywords
-
Journal
TUMORI JOURNAL
Volume 103, Issue 5, Pages 443-448
Publisher
SAGE Publications
Online
2017-07-21
DOI
10.5301/tj.5000632
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pretreatment Immune Parameters Predict for Overall Survival and Toxicity in Early-Stage Non–Small-Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy
- (2016) Narek Shaverdian et al. Clinical Lung Cancer
- Clinical significance of preoperative neutrophil–lymphocyte vs platelet–lymphocyte ratio in primary operable patients with non–small cell lung cancer
- (2015) Hua Zhang et al. AMERICAN JOURNAL OF SURGERY
- Prognostic Significance of Preoperative Neutrophil–Lymphocyte Ratios in Patients with Stage I Non-small Cell Lung Cancer After Complete Resection
- (2015) Yusuke Takahashi et al. ANNALS OF SURGICAL ONCOLOGY
- The relationship between glasgow prognostic score and serum tumor markers in patients with advanced non-small cell lung cancer
- (2015) Ai-Gui Jiang et al. BMC CANCER
- Prognostic value of the neutrophil to lymphocyte ratio in lung cancer: A meta-analysis
- (2015) Y Yin et al. Clinics
- Nomograms Predict Overall Survival for Patients with Small-Cell Lung Cancer Incorporating Pretreatment Peripheral Blood Markers
- (2015) Dong Xie et al. Journal of Thoracic Oncology
- Neutrophil–Lymphocyte and Platelet–Lymphocyte Ratios as Prognostic Factors after Stereotactic Radiation Therapy for Early-Stage Non–Small-Cell Lung Cancer
- (2015) Nathan A. Cannon et al. Journal of Thoracic Oncology
- Preoperative neutrophil/lymphocyte ratio and prognostic nutritional index predict survival in patients with non-small cell lung cancer
- (2015) Katsuhiko Shimizu et al. World Journal of Surgical Oncology
- Combination of platelet to lymphocyte ratio and neutrophil to lymphocyte ratio is a useful prognostic factor in advanced non-small cell lung cancer patients
- (2015) Guannan Wu et al. Thoracic Cancer
- Elevated neutrophil-to-lymphocyte ratio predicts poor outcome in patients with advanced non-small-cell lung cancer receiving first-line gefitinib or erlotinib treatment
- (2014) Gui-Nan Lin et al. Asia-Pacific Journal of Clinical Oncology
- Prognostic Significance of Basic Laboratory Methods in Non-Small-Cell-Lung Cancer
- (2014) Vildan Kaya et al. Asian Pacific Journal of Cancer Prevention
- Are Neutrophil/Lymphocyte and Platelet/Lymphocyte Rates in Patients with Non-Small Cell Lung Cancer Associated with Treatment Response and Prognosis?
- (2014) Dilek Unal et al. Asian Pacific Journal of Cancer Prevention
- Could the Neutrophil to Lymphocyte Ratio be a Poor Prognostic Factor for Non Small Cell Lung Cancers?
- (2014) Turgut Kacan et al. Asian Pacific Journal of Cancer Prevention
- Prognostic performance of inflammation-based prognostic indices in primary operable non-small cell lung cancer
- (2014) D J Pinato et al. BRITISH JOURNAL OF CANCER
- The Glasgow prognostic score as a prognostic factor in patients with advanced non-small cell lung cancer treated with cisplatin-based first-line chemotherapy
- (2014) Ai-Gui Jiang et al. JOURNAL OF CHEMOTHERAPY
- Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
- (2014) Arnoud J. Templeton et al. JNCI-Journal of the National Cancer Institute
- Clinical significance of the neutrophil–lymphocyte ratio in venous thromboembolism patients with lung cancer
- (2014) Se-Il Go et al. LUNG CANCER
- Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective review
- (2013) Syed H Jafri et al. BMC CANCER
- The systemic inflammation-based neutrophil–lymphocyte ratio: Experience in patients with cancer
- (2013) Graeme J.K. Guthrie et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma WithEGFRMutations
- (2013) Lecia V. Sequist et al. JOURNAL OF CLINICAL ONCOLOGY
- A Prognostic Indicator of Survival in Metastatic Colorectal Cancer Patients in the Era of Molecular-Targeted Agents: The Modified Glasgow Prognostic Score
- (2013) Johann Dreanic et al. ONCOLOGY
- The Glasgow Prognostic Score as a Predictor of Survival in Patients with Potentially Resectable Pancreatic Adenocarcinoma
- (2012) Marco La Torre et al. ANNALS OF SURGICAL ONCOLOGY
- Pretreatment neutrophil to lymphocyte ratio is associated with response to therapy and prognosis of advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy
- (2012) Yanwen Yao et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Neutrophil to lymphocyte ratio (NLR) as an indicator of poor prognosis in stage IV non-small cell lung cancer
- (2012) S. Cedrés et al. Clinical & Translational Oncology
- Glasgow Prognostic Score as a useful prognostic factor after hepatectomy for hepatocellular carcinoma
- (2012) Kei Horino et al. International Journal of Clinical Oncology
- Early neutrophil-to-lymphocyte ratio reduction as a surrogate marker of prognosis in never smokers with advanced lung adenocarcinoma receiving gefitinib or standard chemotherapy as first-line therapy
- (2012) Youngjoo Lee et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Clinical Utility of the Pretreatment Glasgow Prognostic Score in Patients with Advanced Inoperable Non-small Cell Lung Cancer
- (2012) Elaine Y.L. Leung et al. Journal of Thoracic Oncology
- Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
- (2012) Rafael Rosell et al. LANCET ONCOLOGY
- Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
- (2012) Julian R. Molina et al. MAYO CLINIC PROCEEDINGS
- Preoperative lymphocyte count is a favorable prognostic factor of disease-free survival in non-small-cell lung cancer
- (2012) Jian Zhang et al. MEDICAL ONCOLOGY
- Glasgow Prognostic Score is a Predictor of Perioperative and Long-term Outcome in Patients with only Surgically Treated Esophageal Cancer
- (2010) Yogesh K. Vashist et al. ANNALS OF SURGICAL ONCOLOGY
- Immunity, Inflammation, and Cancer
- (2010) Sergei I. Grivennikov et al. CELL
- The Inflammation-Based Glasgow Prognostic Score Predicts Survival in Patients With Cervical Cancer
- (2010) Stephan Polterauer et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
- (2009) Tony S. Mok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neutrophil/lymphocyte ratio and its association with survival after complete resection in non–small cell lung cancer
- (2008) Khaled M. Sarraf et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now